Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19 DOI Creative Commons
Juan Marco Figueira Gonçálves, Miguel Ángel García Bello, Yolanda Ramallo‐Fariña

et al.

International Journal of COPD, Journal Year: 2023, Volume and Issue: Volume 18, P. 2473 - 2481

Published: Nov. 1, 2023

Background: Chronic obstructive pulmonary disease (COPD) has been associated with worse clinical evolution/survival during a hospitalization for SARS-CoV2 (COVID-19). The objective of this study was to learn the situation these patients at discharge as well risk re-admission/mortality in following 12 months. Methods: We carried out subanalysis RECOVID registry. A multicenter, observational that retrospectively collected data on severe acute COVID-19 episodes and follow-up visits up year survivors. collection protocol includes general demographic data, smoking, comorbidities, pharmacological treatment, infection severity, complications required treatment. At discharge, resting oxygen saturation (SpO2), dyspnea according mMRC (modified Medical Research Council) scale long-term therapy prescription were recorded. database included management 6 months, where re-admission mortality Results: total 2047 (5.6% had COPD diagnosis). greater need home oxygen. After adjusting age, sex Charlson comorbidity index, hospital due respiratory causes (HR 2.57 [1.35– 4.89], p = 0.004), no significant differences survival. Conclusion: Patients who overcome serious show causes. Keywords: chronic disease, COPD, COVID-19, coronavirus 2019, RECOVID, Spanish registry, SARS-CoV2, syndrome 2, SEPAR, failure

Language: Английский

Trends in mortality in Spain, with a special focus on respiratory-related conditions in the midst of the COVID-19 pandemic DOI
Adrián Peláez, Joan B. Soriano,

María Rodrigo-García

et al.

Medicina Clínica (English Edition), Journal Year: 2025, Volume and Issue: 164(1), P. 1 - 9

Published: Jan. 1, 2025

Language: Английский

Citations

0
Vergleich zwischen COVID-19-bedingten und anderen natürlichen Todesfällen während der ersten fünf Pandemiewellen DOI Creative Commons

Andrea Buschner,

Katharina Katz,

Andreas Beyerlein

et al.

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Journal Year: 2024, Volume and Issue: 67(8), P. 939 - 946

Published: July 16, 2024

Older age is a risk factor for fatal course of SARS-CoV‑2 infection, possibly due to comorbidities whose exact role in this context, however, not yet well understood. In paper, the characteristics and persons who had died COVID-19 Bavaria by July 2022 are shown compared with other fatalities during pandemic.

Language: Английский

Citations

3
Mortality and COVID Infection: Predictors of Mortality 10 Months after Discharge DOI Creative Commons
Víctor Eugenio Vera-Delgado,

Dácil García-Rosado,

Onán Pérez‐Hernández

et al.

Diseases, Journal Year: 2024, Volume and Issue: 12(6), P. 123 - 123

Published: June 5, 2024

Background: The long-term survival of patients hospitalized with COVID-19 and the factors associated poorer months after infection are not well understood. aims present study were to analyze overall mortality 10 admission. Methods: 762 disease included. Patients underwent a complete clinical evaluation, routine laboratory analysis chest X-ray. Data collected included demographic data, such as vascular risk factors, tobacco or alcohol use, comorbidity, institutionalization. Results: Ten-month was 25.6%: 108 deaths occurred in-hospital, while 87 died discharge. In-hospital independently related NT-proBNP values > 503.5 pg/mL [OR = 4.67 (2.38–9.20)], urea 37 mg/dL [3.21 (1.86–7.31)] age older than 71 years 1.93 (1.05–3.54)]. 5.00 (3.06–8.19)], [3.51 (1.97–6.27)], cognitive impairment 1.96 (1.30–2.95), cancer 2.23 (1.36–3.68), leukocytes 6330/mm3 1.64 (1.08–2.50)], mortality. Conclusions: death remains high even infection. Overall during hospital discharge is nearly that observed Comorbidities impairment, organ dysfunction inflammatory reaction independent prognostic markers

Language: Английский

Citations

1
The Influence of SARS-CoV-2 Vaccination on the Mortality and Outcomes of Patients with Both Myocardial Infarction and COVID-19 DOI Creative Commons
Eugeniusz Hrycek, Anna Walawska‐Hrycek, Krzysztof Milewski

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(9), P. 983 - 983

Published: Aug. 29, 2024

This multi-site retrospective analysis with a control group was devised to evaluate the impact of prophylactic SARS-CoV-2 vaccination on outcomes myocardial infarction (MI) patients confirmed COVID-19.

Language: Английский

Citations

1
The status and influencing factors of COVID-19 vaccination in patients with COPD DOI Creative Commons
Mingzhe Li, Zhang Qiang, Yuanyi Yue

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: July 23, 2024

In this study, we investigated the status and influencing factors of coronavirus disease 2019 (COVID-19) vaccination in patients with chronic obstructive pulmonary (COPD). A questionnaire on COVID-19 COPD was developed. The clinical characteristics, status, other relevant vaccinations, were collected anonymously. Logistic regression analysis used to analyze COPD. There 1898 returned questionnaires, which 1874 valid. proportion who completed program 78.60%. Factors rate were: age individuals 75–85 years old > 85 old, acute exacerbation 3–4 times previous year, comorbid cardiovascular endocrine system diseases, failure take regular medication for COPD, application non-invasive ventilation machines, believing that their current health condition has deteriorated, vaccine is not safe, medical staff specifying whether they would recommend against COVID-19, recommending vaccine, fear adverse reactions aggravation Patients had a high China, whereas pneumonia, influenza, herpes zoster low rate. Improving patients' understanding safety effectiveness promoting effective communication between help increase

Language: Английский

Citations

0
Trends in mortality in Spain, with a special focus on respiratory-related conditions in the midst of the COVID-19 pandemic DOI
Adrián Peláez, Joan B. Soriano,

María Rodrigo-García

et al.

Medicina Clínica, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

0
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19 DOI Creative Commons
Juan Marco Figueira Gonçálves, Miguel Ángel García Bello, Yolanda Ramallo‐Fariña

et al.

International Journal of COPD, Journal Year: 2023, Volume and Issue: Volume 18, P. 2473 - 2481

Published: Nov. 1, 2023

Background: Chronic obstructive pulmonary disease (COPD) has been associated with worse clinical evolution/survival during a hospitalization for SARS-CoV2 (COVID-19). The objective of this study was to learn the situation these patients at discharge as well risk re-admission/mortality in following 12 months. Methods: We carried out subanalysis RECOVID registry. A multicenter, observational that retrospectively collected data on severe acute COVID-19 episodes and follow-up visits up year survivors. collection protocol includes general demographic data, smoking, comorbidities, pharmacological treatment, infection severity, complications required treatment. At discharge, resting oxygen saturation (SpO2), dyspnea according mMRC (modified Medical Research Council) scale long-term therapy prescription were recorded. database included management 6 months, where re-admission mortality Results: total 2047 (5.6% had COPD diagnosis). greater need home oxygen. After adjusting age, sex Charlson comorbidity index, hospital due respiratory causes (HR 2.57 [1.35– 4.89], p = 0.004), no significant differences survival. Conclusion: Patients who overcome serious show causes. Keywords: chronic disease, COPD, COVID-19, coronavirus 2019, RECOVID, Spanish registry, SARS-CoV2, syndrome 2, SEPAR, failure

Language: Английский

Citations

1